Test Price
2,800 AEDโ Home Collection Available
MBL2 Gene Mannose-Binding Protein Deficiency Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Analytical Sensitivity (NGS) via ISO 9001:2015 Accredited Lab โ validated for all coding exons & splice junctions.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The MBL2 Genetic Test screens for pathogenic variants in the mannose-binding lectin 2 gene, the most common cause of mannose-binding protein deficiency โ an innate immune defect linked to recurrent respiratory and systemic infections. This NGS-based test delivers thorough exon-level coverage, enabling definitive diagnosis or carrier assessment in at-risk individuals.
| Feature | Our MBL2 NGS Test | Closest Alternative (Traditional Antibody/Complement Functional Assays) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; full gene sequencing of all coding regions | Indirect measurement of MBL levels; limited genotype-phenotype correlation |
| Method | Next Generation Sequencing (NGS) with Sanger confirmation | ELISA/functional assays, often not covered by standard panels |
| Turnaround Time | 3 to 4 Weeks | Variable; may require multiple samples & follow-up |
Primary Ordering Specialists: General Physician โ for patients with recurrent sinopulmonary infections; Clinical Immunologist โ comprehensive immunodeficiency workup; Genetic Counsellor / Medical Geneticist โ pedigree analysis and preโtest counselling.
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: โPatients with unexplained recurrent infections often carry hidden genetic defects in the innate immune system. This MBL2 NGS test provides a molecular diagnosis, but I emphasize that genetic results must be interpreted alongside clinical history and complement function. A positive finding does not predict disease severity โ it calls for careful immunological monitoring and family cascade testing.โ
Advisory: Medication & Clinical Management
Do not discontinue prescribed medications (e.g., prophylactic antibiotics, immunomodulators) without consulting your doctor. Genetic test results inform, but do not replace, ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or active severe infection โ postpone collection until clinically stable.
- Known anaphylaxis to phlebotomy materials (inform the team at booking).
- ER Red Flags: Rapidly worsening sepsis, acute respiratory distress, or loss of consciousness โ seek immediate emergency care; do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What exactly does the MBL2 gene test detect, and how does it affect my immunity?
This test identifies pathogenic DNA variants in the MBL2 gene that lead to low or dysfunctional mannose-binding lectin, a key molecule in the innate immune systemโs first line of defence against bacteria and fungi.
2. How should I prepare, and is a genetic counselling session really necessary?
No fasting is required; a blood, extracted DNA or one-drop blood on FTA Card sample is collected by our home phlebotomist, but a pre- genetic counselling session is mandatory to draw a detailed pedigree chart and ensure informed consent.
3. What happens after I receive my result โ can I self-interpret the report?
All results include a thorough clinical interpretation by a DHA-certified physician; a telephone guidance session is provided to explain the findings, risk for family members, and any recommended immunological follow-up.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent requirements adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted, stored securely, and accessed only by authorized healthcare professionals.
Clinical & Logistical Metadata
| Test Name | MBL2 Gene Mannose-Binding Protein Deficiency Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Blood Spot (Peripheral Blood) |
| Methodology Used | Next Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | D84.8 (Other specified immunodeficiencies) |
| LOINC Code | 81351-9 (MBL2 gene mutation analysis in blood or tissue by sequencing) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians